Home/Pipeline/Bicycle Immune Cell Agonists (BICAs)

Bicycle Immune Cell Agonists (BICAs)

Immuno-oncology

DiscoveryActive

Key Facts

Indication

Immuno-oncology

Phase

Discovery

Status

Active

Company

Bicycle Therapeutics

About Bicycle Therapeutics

Bicycle Therapeutics aims to become a world-leading solid tumor medicines company by leveraging its proprietary Bicycle® platform to create precision-guided therapeutics. Its core technology enables the rapid discovery and development of constrained peptides with high affinity and selectivity for challenging targets. The company is progressing multiple clinical-stage oncology assets and has established creative collaborative relationships to expand its technology into anti-infective, cardiovascular, and CNS diseases.

View full company profile

Therapeutic Areas

Oncology Anti-infective Cardiovascular Ophthalmology Dementia Central Nervous System Neuromuscular Respiratory

Other Immuno-oncology Drugs

Drug	Company	Phase	Status
PD-1/PD-L1 Inhibitor Binding Assay Kit	Aurora Biolabs	Commercial	Available
CTLA-4/B7-1 Inhibitor Screening Kit	Aurora Biolabs	Commercial	Available
OX40 & PD-1 Assay	Aurora Biolabs	Commercial	Available